Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|May 1, 2002
Play Botox!: Drug improves lateral browlift
New Orleans - Lateral browlift is an additional benefit of botulinum toxin type A (Botox) treatment for glabellar rhytids, according to a quantitative analysis reported by Alastair Carruthers, M.D., at the annual meeting of the American Academy of Dermatology.
Advertisement
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
4
Nonsteroidal Topicals Guide Special-Site Psoriasis Treatment Decisions
5